Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Acne-induced Hyperpigmentation During Treatment of Acne Vulgaris Subjects With Trifarotene 50 μg/g Cream Versus Vehicle Cream Over 24 Weeks

NCT05089708 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.

NCT NCT05089708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05089708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Acne-induced Hyperpigmentation During Treatment of Acne Vulgaris Subjects With Trifarotene 50 μg/g Cream Versus Vehicle Cream Over 24 Weeks
Lead sponsor
Galderma R&D
Phase
Phase 4
Overall status
Completed
Start date
December 22, 2021
Completion date
December 15, 2022
Enrollment
123 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris